The Jack & Sheryl Morris Cancer Center is now open for patient care! Today we had a very exciting day as we welcomed our first patients into New Jersey’s first freestanding cancer hospital.
This state-of-the-art facility is ready to change the face of cancer care and research for the state of New Jersey and beyond offering wide-ranging advanced oncology care services all under one roof — greatly enhancing the patient experience and providing further ease of access.
A special thank you to @newjerseydevilsofficial, @somersetpatriots and @rutgersu @ruathletics for helping spread joy to our staff, patients and their families!
A heartfelt thank you to @rutgerswbb for visiting us at the Jack & Sheryl Morris Cancer Center today! 🏀
The team spread joy and shared smiles coloring with our pediatric patients and visiting our infusion unit. 🖍️ Your kindness made a difference today – thank you for inspiring hope! ❤️
@rutgerscancerinstitute
@rwjbarnabas_health
#ThrowbackThursday to #ASCO26! We’re proud of our physicians and researchers who contribute to the conversations shaping the future of cancer care, bringing new insights, advancing research, and driving innovation for the patients we serve.
With 39 abstracts, including one LBA, at Rutgers Cancer Institute and RWJBarnabas Health, we are leading the way in groundbreaking research, advancing innovative treatments, and helping shape the future of cancer care.
At Rutgers Cancer Institute and RWJBarnabas Health, our Breast Cancer Program is built around one goal—providing compassionate, comprehensive care for every patient.
Our multidisciplinary team delivers advanced breast cancer treatment options while working together to ensure each patient receives a personalized care plan.
Through close collaboration between providers and researchers, patients have access to leading-edge clinical trials and breakthrough therapies,bringing the future of cancer care closer to home.
Learn more about our Breast Cancer Program at cinj.org/BreastCancer.
View Original on LinkedIn
Investigators from Rutgers Cancer Institute and RWJBarnabas Health reported the extraordinary finding that two patients with metastatic cervical cancer remain in complete remission 10 years after receiving a single infusion of tumor-infiltrating lymphocyte (TIL) therapy.
Read more about this landmark data from Rutgers Cancer Institute and RWJBarnabas Health
https://lnkd.in/eGRkh2kU
Mark and Shelley Lampf, longtime Rutgers University supporters for 48 years, presented a $250,000 gift to Rutgers Cancer Institute in memory of their daughter, Stefanie Lampf Kennedy. Their generosity will support lung cancer research through the foundation established in her name.
Dr. Missak Haigentz, leader of the Lung/Thoracic Oncology Program as well as Chief of Thoracic Medical Oncology and Chief of Head and Neck Medical Oncology at Rutgers Cancer Institute and RWJBarnabas Health, shared this special moment with Mark and Shelley Lampf and continues to advance critical research and care for patients with lung cancer.
Rutgers Research
Rutgers University Foundation
View Original on Facebook











































